Skip to main navigation Skip to search Skip to main content

Induction therapy with adalimumab on top of an aggressive treat-to-target strategy with methotrexate and intraarticular corticosteroid reduces radiographic erosive progression in early rheumatoid arthritis, even after withdrawal of adalimumab. Results of a 2-year trial (OPERA)

Kim Hørslev-Petersen, Lykke Midtbøll Ørnbjerg, Merete Lund Hetland, P. Junker, Jan Pødenphanth, T. Ellingsen, P. Ahlqvist, H.M. Lindegaard, A. Linauskas, A. Schlemmer, M.Y. Dam, I. Hansen, T. Lottenburger, A. Jørgensen, Sophine Boysen Krintel, J. Raun, C.G. Ammitzbøll, Julia Sidenius Johansen, Mikkel Østergaard, K. Steengaard-Pedersen

Original languageEnglish
JournalArthritis & Rheumatism
Volume65
Issue numberSuppl. 10
Pages (from-to)S600-1
Number of pages2
ISSN0004-3591
Publication statusPublished - 2013

Cite this